News
The American College of Radiology updated guidelines on intravenous iodinated construct media use and management of adverse reactions. ICM is widely used in the U.S.. However, there was a lack of ...
In patients with nickel hypersensitivity, there is increased risk for device syndrome within the first 90 days following patent foramen ovale closure.
[30] Patch testing with the whole vaccine, as well as with its individual components in standardized concentrations and vehicles, was performed on the skin after resolution of the reaction.
A non-exhaustive summary of reported cases of cutaneous reactions caused by a metallic implant is given in Table 5. Although many of the patients were patch test positive to their implanted metals ...
Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.
To report SUSPECTED ADVERSE REACTIONS, contact Rhythm Pharmaceuticals at +1 (833) 789-6337 or FDA at 1-800-FDA-1088 or ...
OLPRUVA: 5 new patient enrollment forms were received in Q1 2025, bringing the total from initial product availability in July 2023, and including Zevra's promotion of OLPRUVA since late January 2024, ...
Dr. Onyinye I. Iweala discusses a recently published review that provided updated recommendations for ordering tryptase tests ...
The mislabeling of allergens is a leading cause of food recalls in the U.S., and can have serious or life-threatening implications for those with allergies.
18h
Zacks Investment Research on MSNGE HealthCare Stock May Gain as FDA Approves Optison for Pediatric UseGE HealthCare Technologies Inc. GEHC recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results